المؤلفون: Danyal Daneshdoust, Mingjue Luo, Zaibo Li, Xiaokui Mo, Sahar Alothman, Bhaskar Kallakury, Richard Schlegel, Junran Zhang, Deliang Guo, Priscilla A. Furth, Xuefeng Liu, Jenny Li

المصدر: Cells, Vol 12, Iss 19, p 2388 (2023)

مصطلحات موضوعية: conditionally reprogrammed cells, breast cancer, precision medicine, Cytology, QH573-671

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2073-4409/12/19/2388; https://doaj.org/toc/2073-4409

URL الوصول: https://doaj.org/article/47684bde3c824ba0915d04da340bc0b9

المؤلفون: Danyal Daneshdoust, Ming Yin, Mingjue Luo, Debasish Sundi, Yongjun Dang, Cheryl Lee, Jenny Li, Xuefeng Liu

المصدر: Cells, Vol 12, Iss 13, p 1714 (2023)

مصطلحات موضوعية: conditionally reprogrammed cells, bladder cancer, biomarkers, precision medicine, urine biomarkers, Cytology, QH573-671

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2073-4409/12/13/1714; https://doaj.org/toc/2073-4409

URL الوصول: https://doaj.org/article/c64c7e6e3ed6461b9afbea38b75ecd3b

المؤلفون: Xia, Siyu, Wu, Ming, Chen, Si, Zhang, Tao, Ye, Lina, Liu, Jun, Li, Hui^{Aff1, Aff2}

المصدر: Virologica Sinica: Official Journal of the Chinese Society for Microbiology. 35(3):311-320

المؤلفون: Nancy Palechor-Ceron, Ewa Krawczyk, Aleksandra Dakic, Vera Simic, Hang Yuan, Jan Blancato, Weisheng Wang, Fleesie Hubbard, Yun-Ling Zheng, Hancai Dan, Scott Strome, Kevin Cullen, Bruce Davidson, John F. Deeken, Sujata Choudhury, Peter H. Ahn, Seema Agarwal, Xuexun Zhou, Richard Schlegel, Priscilla A. Furth, Chong-Xian Pan, Xuefeng Liu

المصدر: Cells, Vol 8, Iss 11, p 1327 (2019)

مصطلحات موضوعية: conditionally reprogrammed cells, patient-derived cancer models, organoids, living biobanks, Cytology, QH573-671

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2073-4409/8/11/1327; https://doaj.org/toc/2073-4409

URL الوصول: https://doaj.org/article/34fd46c6c5844396b7c84756c117ab54

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pipsa Saharinen, Swapnil Potdar, Jennifer R. Devlin, Emmy W. Verschuren, Elina A. Kiss, Kaisa Salmenkivi, Ashwini S. Nagaraj, Annabrita Hemmes, Krister Wennerberg, Sarang S. Talwelkar, Mikko I. Mäyränpää

المساهمون: Institute for Molecular Medicine Finland, Helsinki Institute of Life Science HiLIFE, CAN-PRO - Translational Cancer Medicine Program, Research Programs Unit, Department of Biochemistry and Developmental Biology, Helsinki In Vivo Animal Imaging Platform (HAIP), HUSLAB, Department of Pathology, Medicum, Krister Wennerberg / Principal Investigator, Research Group Verschuren Emmy, Lung Cancer Model Systems

المصدر: Talwelkar, S S, Nagaraj, A S, Devlin, J R, Hemmes, A, Potdar, S, Kiss, E A, Saharinen, P, Salmenkivi, K, Mäyränpää, M I, Wennerberg, K & Verschuren, E W 2019, ' Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras-Mutant Lung Cancers ', Molecular Cancer Therapeutics, vol. 18, no. 10, pp. 1863-1874 . https://doi.org/10.1158/1535-7163.MCT-18-0573

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, CARCINOMA, FGFR Inhibition, MODELS, 3122 Cancers, BIOLOGY, CONDITIONALLY REPROGRAMMED CELLS, medicine.disease_cause, THERAPY, Receptor tyrosine kinase, 03 medical and health sciences, ErbB Receptors, 0302 clinical medicine, ErbB, In vivo, medicine, ERBB3, STRATEGY, MEK INHIBITION, neoplasms, biology, Chemistry, ADENOCARCINOMA, DRIVEN, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, biology.protein, Cancer research, KRAS, RESISTANCE, Ex vivo

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2218d9052825458be013ab20778337
https://doi.org/10.1158/1535-7163.mct-18-0573

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Chris Albanese, Adam S. Feldman, Sivanesan Dakshanamurthy, Deepak Kumar, Lucas Tricoli, Henry Walthieu, Erika Parasido, Richard T. Lee, Maria Avantaggiati, Aisha Naeem, Olga Rodriguez, Stephen W. Byers, Muhammad S. Noon

المصدر: The Prostate

مصطلحات موضوعية: 0301 basic medicine, Drug, Male, Proteomics, Urology, media_common.quotation_subject, In silico, Antineoplastic Agents, Drug action, Computational biology, Transcriptome, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Cell Line, Tumor, Medicine, Humans, media_common, Oligonucleotide Array Sequence Analysis, drug repurposing, primary prostate, business.industry, Bortezomib, Drug Repositioning, Prostatic Neoplasms, tissue, Original Articles, medicine.disease, Carfilzomib, conditionally reprogrammed cells, systems network pharmacology, Drug repositioning, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Original Article, Drug Screening Assays, Antitumor, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ea2c6db47a4f7c8b9a8c3d37a61f8c
https://pubmed.ncbi.nlm.nih.gov/32761925

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.